Topiramate: a new potential pharmacological treatment for obesity (Q36027629)

11 August 2017

1 reference

title

Topiramate: a new potential pharmacological treatment for obesity (English)

1 reference

11 August 2017

0 references

1

Arne Astrup

0 references

author name string

Søren Toubro

series ordinal

2

1 reference

11 August 2017

1 December 2004

1 reference

11 August 2017

1 reference

11 August 2017

12 Suppl

1 reference

11 August 2017

167S-73S

1 reference

Prevalence and Trends in Obesity Among US Adults, 1999-2000

11 August 2017

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.284

Relation of weight gain and weight loss on subsequent diabetes risk in overweight adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.284

Overweight and obesity as determinants of cardiovascular risk: the Framingham experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.284

Body mass index and the prevalence of hypertension and dyslipidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.284

Body-Mass Index and Mortality in a Prospective Cohort of U.S. Adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.284

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.284

Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients. European Multicentre Orlistat Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.284

Long-term maintenance of weight loss after a very-low-calorie diet: a randomized blinded trial of the efficacy and tolerability of sibutramine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.284

A 6-month randomized, placebo-controlled, dose-ranging trial of topiramate for weight loss in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.284

Topiramate: long-term maintenance of weight loss induced by a low-calorie diet in obese subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.284

Long-term weight loss with sibutramine: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.284

Sodium reduction and weight loss in the treatment of hypertension in older persons: a randomized controlled trial of nonpharmacologic interventions in the elderly (TONE). TONE Collaborative Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.284

A randomized double-blind placebo-controlled study of the long-term efficacy and safety of topiramate in the treatment of obese subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.284

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.284

The effects of topiramate and sex hormones on energy balance of male and female rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.284

One-year treatment of obesity: a randomized, double-blind, placebo-controlled, multicentre study of orlistat, a gastrointestinal lipase inhibitor

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.284

Orlistat, a lipase inhibitor, for weight maintenance after conventional dieting: a 1-y study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.284

31 March 2020

Identifiers

DOI

10.1038/OBY.2004.284

1 reference

11 August 2017

1 reference

PubMed ID

15687413